Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Skeletal Effects of Inducible ER alpha Deletion in Osteocytes in Adult Mice

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F22%3A10449462" target="_blank" >RIV/00216208:11150/22:10449462 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00179906:_____/22:10449462

  • Výsledek na webu

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7kH0-Y6oZb" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7kH0-Y6oZb</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/jbmr.4644" target="_blank" >10.1002/jbmr.4644</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Skeletal Effects of Inducible ER alpha Deletion in Osteocytes in Adult Mice

  • Popis výsledku v původním jazyce

    Estrogen is known to regulate bone metabolism in both women and men, but substantial gaps remain in our knowledge of estrogen and estrogen receptor alpha (ER alpha) regulation of adult bone metabolism. Studies using global ER alpha-knockout mice were confounded by high circulating sex-steroid levels, and osteocyte/osteoblast-specific ER alpha deletion may be confounded by ER alpha effects on growth versus the adult skeleton. Thus, we developed mice expressing the tamoxifen-inducible CreERT2 in osteocytes using the 8-kilobase (kb) Dmp1 promoter (Dmp1(CreERT2)). These mice were crossed with ER alpha(fl//fl) mice to create ER alpha Delta Ocy mice, permitting inducible osteocyte-specific ER alpha deletion in adulthood. After intermittent tamoxifen treatment of adult 4-month-old mice for 1 month, female, but not male, ER alpha Delta Ocy mice exhibited reduced spine bone volume fraction (BV/TV (-20.1%, p = 0.004) accompanied by decreased trabecular bone formation rate (-18.9%, p = 0.0496) and serum P1NP levels (-38.9%, p = 0.014). Periosteal (+65.6%, p = 0.004) and endocortical (+64.1%, p = 0.003) expansion were higher in ER alpha Delta Ocy mice compared to control (Dmp1(CreERT2)) mice at the tibial diaphysis, reflecting the known effects of estrogen to inhibit periosteal apposition and promote endocortical formation. Increases in Sost (2.1-fold, p = 0.001) messenger RNA (mRNA) levels were observed in trabecular bone at the spine in ER alpha Delta Ocy mice, consistent with previous reports that estrogen deficiency is associated with increased circulating sclerostin as well as bone SOST mRNA levels in humans. Further, the biological consequences of increased Sost expression were reflected in significant overall downregulation in panels of osteoblast and Wnt target genes in osteocyte-enriched bones from ER alpha Delta Ocy mice. These findings thus establish that osteocytic ER alpha is critical for estrogen action in female, but not male, adult bone metabolism. Moreover, the reduction in bone formation accompanied by increased Sost, decreased osteoblast, and decreased Wnt target gene expression in ER alpha Delta Ocy mice provides a direct link in vivo between ER alpha and Wnt signaling. (c) 2022 American Society for Bone and Mineral Research (ASBMR).

  • Název v anglickém jazyce

    Skeletal Effects of Inducible ER alpha Deletion in Osteocytes in Adult Mice

  • Popis výsledku anglicky

    Estrogen is known to regulate bone metabolism in both women and men, but substantial gaps remain in our knowledge of estrogen and estrogen receptor alpha (ER alpha) regulation of adult bone metabolism. Studies using global ER alpha-knockout mice were confounded by high circulating sex-steroid levels, and osteocyte/osteoblast-specific ER alpha deletion may be confounded by ER alpha effects on growth versus the adult skeleton. Thus, we developed mice expressing the tamoxifen-inducible CreERT2 in osteocytes using the 8-kilobase (kb) Dmp1 promoter (Dmp1(CreERT2)). These mice were crossed with ER alpha(fl//fl) mice to create ER alpha Delta Ocy mice, permitting inducible osteocyte-specific ER alpha deletion in adulthood. After intermittent tamoxifen treatment of adult 4-month-old mice for 1 month, female, but not male, ER alpha Delta Ocy mice exhibited reduced spine bone volume fraction (BV/TV (-20.1%, p = 0.004) accompanied by decreased trabecular bone formation rate (-18.9%, p = 0.0496) and serum P1NP levels (-38.9%, p = 0.014). Periosteal (+65.6%, p = 0.004) and endocortical (+64.1%, p = 0.003) expansion were higher in ER alpha Delta Ocy mice compared to control (Dmp1(CreERT2)) mice at the tibial diaphysis, reflecting the known effects of estrogen to inhibit periosteal apposition and promote endocortical formation. Increases in Sost (2.1-fold, p = 0.001) messenger RNA (mRNA) levels were observed in trabecular bone at the spine in ER alpha Delta Ocy mice, consistent with previous reports that estrogen deficiency is associated with increased circulating sclerostin as well as bone SOST mRNA levels in humans. Further, the biological consequences of increased Sost expression were reflected in significant overall downregulation in panels of osteoblast and Wnt target genes in osteocyte-enriched bones from ER alpha Delta Ocy mice. These findings thus establish that osteocytic ER alpha is critical for estrogen action in female, but not male, adult bone metabolism. Moreover, the reduction in bone formation accompanied by increased Sost, decreased osteoblast, and decreased Wnt target gene expression in ER alpha Delta Ocy mice provides a direct link in vivo between ER alpha and Wnt signaling. (c) 2022 American Society for Bone and Mineral Research (ASBMR).

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30202 - Endocrinology and metabolism (including diabetes, hormones)

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2022

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Journal of Bone and Mineral Research

  • ISSN

    0884-0431

  • e-ISSN

    1523-4681

  • Svazek periodika

    37

  • Číslo periodika v rámci svazku

    9

  • Stát vydavatele periodika

    US - Spojené státy americké

  • Počet stran výsledku

    11

  • Strana od-do

    1750-1760

  • Kód UT WoS článku

    000828895500001

  • EID výsledku v databázi Scopus

    2-s2.0-85134468346